Name

Linker Regimen induction

Alternate names

DVPL-ASP
PVDA

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for Linker Regimen induction

Name

Alternate Names

Acetyladriamycin
Cerubidine
Dauno-blastin
Daunomycin
Daunomycin-HCl
Daunorubicin
Daunorubicine
FI-6339
Leuk-aemomycin C
NDC-0082-4155
RP-13057
Rubidomycin
Rubidomycin HCl
Rubomycin C

Abbreviations

Daun
Dauno
DNM
DNR
DRB

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

082151
82151

Primary Site

Leukemia

Histology

None

Remarks

FDA approved use on ALL and ANLL; antitumor antibiotic

Coding

This drug should be coded

Name

Alternate Names

Asnase
Asparaginase (Escherichia coli)
Colaspase
Crasnitin#
EC3.1.5.1.
Elspar
Kidrolase
L-Asparaginase
Leunase (enzyme)
MK-965
Re-82-TAD-15

Abbreviations

ASP
ASPA
L-ASE
L-ASP

Category

Chemotherapy

Subcategory

Antineoplastic agent

NSC Number

109229

Primary Site

Acute lymphoblastic leukemia (ALL)

Histology

None

Remarks

Coding

This drug should be coded

Name

Alternate Names

Alti-Prednisone
Alto-Pred
Ancortone
Apo-Prednisone
Colisone
Cortan
Dacortin
Delta-Dome#
Deltasone
Deltra
Fernisone Buffered
Keysone
Liquid Pred
Meticorten
Novo-Prednisone
Orasone
Panasol
Paracort#
Prednicen M
SK-Prednisone
Sterapred DS
Ultracorten
Winpred

Abbreviations

PDN
PRD
PRED

Category

Hormones and hormonal mechanisms

Subcategory

Glucocorticoid

NSC Number

10023
010023

Primary Site

Prednisone is used in regimens to treat multiple sites and histologies

Histology

None

Remarks

Code Prednisone when it is part of a drug regimen.

Do not code Prednisone when it is given to treat symptoms or as a single agent. In most cases when Prednisone is given by itself and not as part of a drug regimen, it does not affect the cancer and would not be coded as treatment.

Coding

Please see remarks for additional information

Name

Alternate Names

Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin

Abbreviations

LCR
VCR
VNCR

Category

Chemotherapy

Subcategory

Plant alkyloid--antimetabolite

NSC Number

067574
67574

Primary Site

None

Histology

None

Remarks

Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.

Coding

This drug should be coded
Glossary